KPMA seeking extension of tax exemption for drug R&D investment.

The KPMA is trying hard to keep extension of the government's tax exemption for the drug R&D investment, which was estimated to 530 BW, by quoting other countries where their pharmaceutical industrial development had been largely bolstered by the government's tax privileges for the drug R&D expenditures.

The KPMA presented a recommendation letter to the government ministries such as the MOHW...